Dr. Clara Campàs is partner and co-founder at the venture capital firm ASABYS Partners (Barcelona). Formerly, she served as Strategy & Development Director at Kern Pharma (2014-2018) and held several positions at Advancell (2006-2014), including managing director (2012-2014). Dr. Campàs has served as a member of the Investment Committee of the venture capital firm HealthEquity (2015-2018), as well as vice-president of CataloniaBIO (2014-2017) and member of the Board of Directors of Biocat (2015-2017). She acted as a mentor in several programs such as d-Health MOEBIO, Caixaimpulse and the BCN Mentoring Program. Dr. Campàs is co-author of the Acadesine patent (the first Spanish patent from a public University reaching clinical trials successfully). Up to 2006, Dr. Campàs was a researcher engaged in the development of new therapies in cancer. Dr. Campàs has published extensively in peer-reviewed scientific journals as well in the medical literature. She received her Doctorate in Pharmacy in 2004 and a Master’s in Pharmacy from the University of Barcelona in 1999.